View in EDS

Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants.

Saved in:
Bibliographic Details
Title: Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants.
Authors: Perdrizet J; Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA., Santana CFS; Health Economics and Outcomes Research, Pfizer Inc, Sao Paulo, Brazil., Senna T; Health Economics and Outcomes Research, Pfizer Inc, Sao Paulo, Brazil., Alexandre RF; Health Economics and Outcomes Research, Pfizer Inc, Sao Paulo, Brazil., Sini de Almeida R; Medical and Scientific Affairs, Pfizer Inc, Sao Paulo, Brazil., Spinardi J; Medical and Scientific Affairs, Pfizer Inc, Sao Paulo, Brazil., Wasserman M; Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA.
Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Apr 03; Vol. 17 (4), pp. 1162-1172. Date of Electronic Publication: 2020 Sep 23.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32966176
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Perdrizet+J%22">Perdrizet J</searchLink>; Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Santana+CFS%22">Santana CFS</searchLink>; Health Economics and Outcomes Research, Pfizer Inc, Sao Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Senna+T%22">Senna T</searchLink>; Health Economics and Outcomes Research, Pfizer Inc, Sao Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Alexandre+RF%22">Alexandre RF</searchLink>; Health Economics and Outcomes Research, Pfizer Inc, Sao Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Sini+de+Almeida+R%22">Sini de Almeida R</searchLink>; Medical and Scientific Affairs, Pfizer Inc, Sao Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Spinardi+J%22">Spinardi J</searchLink>; Medical and Scientific Affairs, Pfizer Inc, Sao Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Wasserman+M%22">Wasserman M</searchLink>; Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101572652%22">Human vaccines & immunotherapeutics</searchLink> [Hum Vaccin Immunother] 2021 Apr 03; Vol. 17 (4), pp. 1162-1172. <i>Date of Electronic Publication: </i>2020 Sep 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101572652 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2164-554X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221645515%22">21645515 </searchLink><i>NLM ISO Abbreviation: </i>Hum Vaccin Immunother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32966176
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/21645515.2020.1809266
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1162
    Titles:
      – TitleFull: Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Perdrizet J
      – PersonEntity:
          Name:
            NameFull: Santana CFS
      – PersonEntity:
          Name:
            NameFull: Senna T
      – PersonEntity:
          Name:
            NameFull: Alexandre RF
      – PersonEntity:
          Name:
            NameFull: Sini de Almeida R
      – PersonEntity:
          Name:
            NameFull: Spinardi J
      – PersonEntity:
          Name:
            NameFull: Wasserman M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 04
              Text: 2021 Apr 03
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2164-554X
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Human vaccines & immunotherapeutics
              Type: main
ResultId 1